News

Latest News

NewAmsterdam Pharma and the Menarini Group Sign Licensing Deal to Commercialize Obicetrapib in Europe

NewAmsterdam Pharma and the Menarini Group Sign Licensing Deal to Commercialize Obicetrapib in Europe

Naarden, the Netherlands, Miami, USA and Florence, Italy; June 28, 2022 – NewAmsterdam Pharma (NewAmsterdam), a clinical-stage company focused on the research and development of...
The XXVI Fair Play Menarini International Award opens with a press conference at CONI

The XXVI Fair Play Menarini International Award opens with a press conference at CONI

ROME – The opening whistle has blown for the XXVI Fair Play Menarini International Award. This morning, the Salone d’Onore at CONI (the Italian National Olympic Committee) in...
Menarini Group and Radius Health Submit New Drug Application to the U.S. FDA for Elacestrant

Menarini Group and Radius Health Submit New Drug Application to the U.S. FDA for Elacestrant

Florence, Italy and Boston, Mass., June 22, 2022 – The Menarini Group (“Menarini”) and Radius Health, Inc. (“Radius”) (NASDAQ: RDUS) (collectively, the...
Menarini Group and Radius Health, Inc. present a subgroup analysis from the elacestrant pivotal phase 3 EMERALD clinical trial at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

Menarini Group and Radius Health, Inc. present a subgroup analysis from the elacestrant pivotal phase 3 EMERALD clinical trial at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

Florence, Italy and Boston, Mass., June 6, 2022 - The Menarini Group (“Menarini”) and Radius Health, Inc. (“Radius”) (NASDAQ: RDUS) (collectively, the...
Menarini inaugurates new regional headquarters in Dubai, UAE

Menarini inaugurates new regional headquarters in Dubai, UAE

The pharmaceutical group, present in 140 countries in the world, aims to raise standard of patient healthcare across the Middle East and Africa (MEA) region with innovative products and breakthrough research

Dubai, United Arab Emirates, 26 May 2022: Menarini, the leading Italian pharmaceutical group founded in 1886, today opened its regional headquarters in Dubai Science Park as part of its...
Karyopharm and Menarini Group Receive Positive CHMP Opinion for NEXPOVIO® (selinexor) for the Treatment of Patients with Refractory Multiple Myeloma

Karyopharm and Menarini Group Receive Positive CHMP Opinion for NEXPOVIO® (selinexor) for the Treatment of Patients with Refractory Multiple Myeloma

NEWTON, Mass. and FLORENCE, Italy – May 20th, 2022 – Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies,...
Menarini Group and Radius Health, Inc. announce publication of elacestrant pivotal Phase 3 EMERALD clinical trial data in the Journal of Clinical Oncology

Menarini Group and Radius Health, Inc. announce publication of elacestrant pivotal Phase 3 EMERALD clinical trial data in the Journal of Clinical Oncology

May 20, 2022

Florence, Italy and Boston, Mass., May 20, 2022 - The Menarini Group (“Menarini”) and Radius Health, Inc. (“Radius”) (NASDAQ: RDUS) (collectively, the...
Berlin-Chemie Menarini’s position in Ukraine

Berlin-Chemie Menarini’s position in Ukraine

We continue to be deeply concerned by the tragic situation in Ukraine, the devastating losses of civilians and the suffering of the entire Ukrainian population.

MENARINI DIAGNOSTICS DETECTS ALL COVID VARIANTS

MENARINI DIAGNOSTICS DETECTS ALL COVID VARIANTS

Menarini’s novel CoronaMeltVAR test detects SARS CoV-2 and discriminates the potential presence of the Delta, Omicron BA.1 or Omicron BA.2 variants

Menarini’s novel CoronaMeltVAR test detects SARS CoV-2 and discriminates the potential presence of the Delta, Omicron BA.1 or Omicron BA.2...
Conversations with Nobel Prize Winners: The Fondazione Menarini launches their “Dialogs Beyond Borders” series

Conversations with Nobel Prize Winners: The Fondazione Menarini launches their “Dialogs Beyond Borders” series

Who are the heroes that have inspired the careers of Nobel Prize winners? What difficulties have they encountered and how did they overcome them? Each and every one of us can now delve...
Menarini Diagnostics CoronaMeltVAR Real-Time PCR kit  simultaneously detects  SARS CoV-2 and identifies the Omicron Variant

Menarini Diagnostics CoronaMeltVAR Real-Time PCR kit simultaneously detects SARS CoV-2 and identifies the Omicron Variant

The new Omicron variant is spreading rapidly causing an increase in infections at unprecedented speed. On November 28th, WHO officially recommended laboratories to use Real Time PCR...
Pope Francis welcomes in audience the Fair Play Menarini Award

Pope Francis welcomes in audience the Fair Play Menarini Award

In the year of its 25th anniversary, a delegation of Menarini Fair Play Ambassadors was received in audience by the Holy Father in the Paul VI Audience Hall

VATICAN CITY, December 22nd, 2021 - This morning, in the solemn setting of the Paul VI Audience Hall, a delegation of Fair Play Menarini Ambassadors was received in audience by the Holy...
Karyopharm and Menarini Group Enter into Exclusive License Agreement to Commercialize NEXPOVIO® (selinexor) in Europe and Other Key Global Territories

Karyopharm and Menarini Group Enter into Exclusive License Agreement to Commercialize NEXPOVIO® (selinexor) in Europe and Other Key Global Territories

Menarini Group Obtains Exclusive Rights to Commercialize NEXPOVIO for the Treatment of Hematologic and Solid Tumor Oncology Indications in Europe (including the United Kingdom), Latin America and Other Key Countries Karyopharm to Receive $75 Million Upfront, then Eligible to Receive Up to $202.5 Million in Future Milestones, Plus Tiered, Double-digit Royalties on Net Sales

Menarini Group Obtains Exclusive Rights to Commercialize NEXPOVIO for the Treatment of Hematologic and Solid Tumor Oncology Indications in Europe (including the United Kingdom), Latin...
Menarini Silicon Biosystems announces new DEPArray™ PLUS application to identify mutations in FFPE tissue samples with low tumor cellularity

Menarini Silicon Biosystems announces new DEPArray™ PLUS application to identify mutations in FFPE tissue samples with low tumor cellularity

Tissue biopsies with tumor cell contents that are too low for conventional testing methods can now be rescued due to the ability of MSB’s DEPArray technology* to successfully...
Menarini Silicon Biosystems Announces study results to be presented at American Society of Hematology (ASH) Annual Meeting

Menarini Silicon Biosystems Announces study results to be presented at American Society of Hematology (ASH) Annual Meeting

Menarini Silicon Biosystems Announces study results to be presented at American Society of Hematology (ASH) Annual Meeting Highlighting CELLSEARCH® CMMC assay, a Non-Invasive Liquid...
Menarini: a gift to the Misericordia Campo di Marte to give life to their new ‘home’

Menarini: a gift to the Misericordia Campo di Marte to give life to their new ‘home’

Florence, 10th December 2021 - Menarini has chosen to support the historic Misericordia Campo di Marte San Pietro Martire, through a donation towards the building of their new 'home'. It will be a completely eco-sustainable building, close to where their current operations centre is, in Florence’s Quartiere 2, the same area where the multinational pharmaceutical company is based. The construction of the building is already underway and, thanks to this new, over 300 square metre building, the association will soon be able to provide a greater number of services to the public.

Florence, 10th December 2021 - Menarini has chosen to support the historic Misericordia Campo di Marte San Pietro Martire, through a donation towards the building of their new...
Positive EMERALD Trial Results for Elacestrant Presented at San Antonio Breast Cancer Symposium 2021

Positive EMERALD Trial Results for Elacestrant Presented at San Antonio Breast Cancer Symposium 2021

Florence, Italy and Boston, Mass., December 8, 2021 – the Menarini Group (“Menarini”) and Radius Health, Inc. (“Radius”) (NASDAQ: RDUS) (collectively, the...
1345678910Last

News Archive

 

Company Profile

Download Pdf

youtube Youtube

linkedin Linkedin

Blog Item Image
MENARINI EMPLOYEES
make all the difference, every day.

We are looking for talented people: in order to achieve our mission we need energetic, versatile people with initiative and team-work skills.
Every day we do our jobs with a great sense of commitment, knowing that we are adding more value to the creation of quality drugs.

READ MORE




menarini pills of art

Menarini Pills of Art

Today, with ‘Pills of Art’, Menarini enters the city’s museums to reveal some of the curious facts on the works of the most well-known Renaissance painters. An initiative which confirms the company’s affiliation with art, a close connection which has led them to publish, each year and for more than six decades, an art monograph

Read More
Fair Play Menarini

International Fair Play Menarini Award

International Fair Play Menarini Award: the annual event which celebrates those sporting champions who have stood out in the world of sports for the brilliant results attained whilst fully respecting the rules

Read More
Menarini and Farmindustria

Menarini and Farmindustria: together we won’t rest

COVID -19 has brought many changes to our habits and our daily lives, but together we can face - and overcome - our fears. Menarini and Farmindustria, like all of us, won't rest.

Read More
EFPIA

EFPIA - We won’t rest campaign

MENARINI SUPPORTS THE EFPIA CAMPAIGN - WE WON'T REST: Disease never takes a break, so neither do we. We won't rest until people around the world see a brighter tomorrow.

Read More
newsletter

Subscribe to the newsletter

Subscribe to the newsletter to be updated on Menarini news.

Subscribe
Media Contact

Media Contact

To access the service it is necessary to declare to have read the privacy information.

Read More

The Menarini Blog

MENARINI BLOG

  • Menarini4People
Menarini promotes sport as a path for social inclusion
Read More
  • WeAreMenarini
Face-to-face with the future: Menarini returns to in-person interviews with candidates
Read More
  • WeAreMenarini
Women and Pharma: the Menarini model
Read More

menarini for people

Discover our responsibility projects to stand close to people

read more